The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Christopher Nishan Garabedian since 2011.
The trader's CIK number is 1492604.
At the time of the last reporting, Christopher Nishan Garabedian was the President and CEO of Sarepta Therapeutics, Inc.. (stock ticker symbol SRPT).
Also see all insider trading activities at Sarepta Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | SRPT | 800 | $9,452 | 0 | $0 | 0 | $0 |
| 2011 | SRPT | 430,000 | $368,700 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-02-27 | SRPT | Buy | 800 | 11.81 | 9,452 |
| 2011-12-15 | AVII | Buy | 300,000 | .58 | 173,700 |
| 2011-04-06 | AVII | Buy | 130,000 | 1.50 | 195,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Christopher Nishan Garabedian (President and CEO of Sarepta Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.